Background: Excess fluid accumulation (seroma/hematoma) around the breast implant after
reconstruction can lead to significant complications. Topical administration of tranexamic …

Tranexamic acid (TXA) is an anti-fibrinolytic agent originally developed for the management
of bleeding in the setting of post-partum hemorrhage (PPH). Over the last 15 years, there …

Abstract Background Postpartum Hemorrhage (PPH) is one of the main causes of maternal
mortality, mainly in the poorest regions of the world, drawing attention to the need for …

Burn injury causes a coagulopathy that is poorly understood. After severe burns, significant
fluid losses are managed by aggressive resuscitation that can lead to hemodilution. These …

Background The use of tranexamic acid (TXA) is associated with less blood loss and
reduced transfusion risk after shoulder arthroplasty surgery. Recent studies have shown …

BACKGROUND Tranexamic acid (TXA) is an antifibrinolytic that has shown some promise in
improving outcomes in traumatic brain injury (TBI), but only when given early after injury. We …

Background: Early resuscitation with blood components or products is emerging as best
practice in selected patients with trauma and medical patients; as a result, out-of-hospital …

The musculoskeletal system plays vital roles in the body, facilitating movement, protecting
vital structures, and regulating hematopoiesis and mineral metabolism. Injuries to this …

Background The aim of this study was to determine when and how rapid response vehicles
(RRVs) make a difference in prehospital care by investigating the number and kinds of RRV …

ObjectivePost-tonsillectomy haemorrhage is an increasingly common cause of morbidity
following tonsillectomy. Secondary post-tonsillectomy haemorrhage occurring more than 24 …